Global Cardiovascular Drug Trends in 2022
Cardiovascular Drug is part of Therapy and includes a number of sub-sectors such as Antihypertensive. You may also be interested in Anesthetics, Anti-Infective and Hormone.
Global sales of beta blocking medicines are set to reach $2.4 billion by 2026, after rising 2.4% each year since 2017. In 2021, Germany topped the list with sales of $815.9 million, followed by Italy, Canada and Australia. Portugal saw a 5.5% year-on-year increase in sales, while Costa Rica experienced a 5.4% decrease.
Top 10 countries
In 2022 major markets in the Cardiovascular Drug Industry were:
Cardiovascular Drug Market Data and Forecasts
How much the Cardiovascular Drug industry is expected to grow to 2026?
More in Cardiovascular Drug Industry for 2028Global Cardiovascular Drug Statistics
- Antihypertensive Medicine Sales 42 countries (Europe, Northern Europe, Southern Europe...)
- Cardiovascular System Medicine Sales 46 countries (Europe, Northern Europe, Southern Europe...)
- Diuretic Medicine Sales 42 countries (Europe, Northern Europe, Southern Europe...)
- Beta Blocking Medicine Sales 42 countries (Europe, Northern Europe, Southern Europe...)
- Antiarrhythmic Medicine Sales 42 countries (Europe, Northern Europe, Southern Europe...)
- Calcium Channel Blocking Medicine Sales 42 countries (Europe, Northern Europe, Southern Europe...)
- Medicine Use 130 countries (Europe, Northern Europe, Latin America...)